Gopalakrishnan and colleagues demonstrated that transferring stool from anti-PD-1 nonresponders expands the number of tumor-infiltrating RORγt+ Th17 cells and splenic CD4+IL-17+ Tregs in recipient mice, indicating that the gut microbiota drives immunosuppression in a Th17-dependent manner [111]. This evidence concerns the gene CD4 and neoplasm.